PLUR - Pluri Inc.

Insider Purchase by Manieu Alexandre Weinstein (Dir, 10%)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

10 months ago, Manieu Alexandre Weinstein, serving as Dir, 10% owner at Pluri Inc. (PLUR), purchased 452,702 shares at $4.61 per share, for a total transaction value of $2,086,956.00. Following this transaction, Manieu Alexandre Weinstein now holds 2,396,367 shares of PLUR.

This purchase represents a 23.00% increase in Manieu Alexandre Weinstein's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 28, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, November 20, 2025, 206 days after the trade was made.

Pluri Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Manieu Alexandre Weinstein

Dir, 10%

Manieu Alexandre Weinstein, also known as Alejandro Weinstein, is a prominent global investor and director at Pluri Inc. (NASDAQ: PLUR), where he serves as a 10% owner through his entity Chutzpah Holdings Ltd and was recently appointed Chairman of the Board in December 2025[[2]](https://www.pharmanow.live/latest-news/pluri-weinstein-chairman-investment)[[6]](https://www.marketscreener.com/news/pluri-inc-announces-chairman-of-the-board-of-directors-changes-ce7d51d2d08ef020). He has demonstrated strong commitment to the company through significant share purchases, including 452,702 shares at $4.61 totaling $2.086 million on October 29, 2025, and additional transactions elevating his holdings to over 1.3 million shares valued at approximately $4 million as of April 2025[[1]](https://www.investing.com/news/insider-trading-news/pluri-inc-director-weinstein-buys-shares-worth-208-million-93CH-4371079)[[4]](https://www.gurufocus.com/insider/185964/alexandre-weinstein-manieu)[[5]](https://www.secform4.com/insider-trading/1833124.htm). Weinstein's career highlights include transforming CFR Pharmaceuticals into a multinational company acquired by Abbott for $2.9 billion, and founding investment firms such as WM Partners, Olive Tree Ventures, and Vanterra Ventures, focusing on healthcare, biotechnology, wellness, and nutrition innovation[[2]](https://www.pharmanow.live/latest-news/pluri-weinstein-chairman-investment)[[6]](https://www.marketscreener.com/news/pluri-inc-announces-chairman-of-the-board-of-directors-changes-ce7d51d2d08ef020). Residing in Switzerland, he brings expertise in scaling companies and executing major transactions to guide Pluri's cell therapy platform commercialization[[9]](https://www.sec.gov/Archives/edgar/data/1158780/000121390026001394/ea027187001-ex1_pluri.htm)[[2]](https://www.pharmanow.live/latest-news/pluri-weinstein-chairman-investment).

View full insider profile →

Trade Price

$4.61

Quantity

452,702

Total Value

$2,086,956.00

Shares Owned

2,396,367

Trade Date

Monday, April 28, 2025

300 days ago

SEC Filing Date

Thursday, November 20, 2025

Filed 206 days after trade

HEALTHCAREBIOTECHNOLOGY

About Pluri Inc.

Company Overview

No company information available
View news mentioning PLUR

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/1295352

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime